HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jasti S Rao Selected Research
Jasti S Rao Research Topics
Disease
98
Neoplasms (Cancer)
11/2020 - 08/2002
64
Glioma (Gliomas)
04/2021 - 01/2002
26
Glioblastoma (Glioblastoma Multiforme)
01/2021 - 11/2002
16
Neoplasm Metastasis (Metastasis)
10/2013 - 10/2005
14
Meningioma (Meningiomas)
01/2021 - 02/2003
9
Medulloblastoma
05/2014 - 05/2007
8
Infections
06/2008 - 11/2002
7
Prostatic Neoplasms (Prostate Cancer)
11/2020 - 04/2005
7
Brain Neoplasms (Brain Tumor)
10/2013 - 12/2002
6
Breast Neoplasms (Breast Cancer)
09/2011 - 04/2006
5
Spinal Cord Injuries (Spinal Cord Injury)
09/2012 - 01/2008
5
Lung Neoplasms (Lung Cancer)
09/2010 - 09/2005
4
Neuroblastoma
01/2013 - 01/2012
4
Hypoxia (Hypoxemia)
01/2012 - 09/2010
2
Pancreatic Neoplasms (Pancreatic Cancer)
09/2013 - 04/2011
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2013 - 04/2011
2
Leukemia
01/2013 - 04/2005
2
Inflammation (Inflammations)
06/2012 - 10/2009
2
Adenocarcinoma
02/2012 - 04/2011
2
Heart Failure
05/2010 - 08/2009
2
Pathologic Processes
10/2009 - 11/2002
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2014
1
Stroke (Strokes)
02/2014
1
Brain Ischemia (Cerebral Ischemia)
02/2014
Drug/Important Bio-Agent (IBA)
44
Small Interfering RNA (siRNA)
IBA
05/2014 - 05/2004
36
Proteins (Proteins, Gene)
FDA Link
05/2014 - 12/2002
32
Urokinase Plasminogen Activator Receptors
IBA
11/2020 - 01/2002
25
Cathepsin B
IBA
04/2021 - 12/2002
20
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
11/2020 - 11/2002
20
Peptide Hydrolases (Proteases)
FDA Link
09/2012 - 02/2003
19
Matrix Metalloproteinases (MMPs)
IBA
01/2021 - 02/2003
15
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
11/2020 - 11/2002
15
Plasminogen Activators (Plasminogen Activator)
IBA
11/2020 - 02/2003
15
matrigel
IBA
12/2013 - 11/2002
14
Integrins
IBA
01/2021 - 07/2010
10
Messenger RNA (mRNA)
IBA
02/2014 - 07/2003
8
Conditioned Culture Media
IBA
04/2013 - 03/2004
8
DNA (Deoxyribonucleic Acid)
IBA
02/2013 - 07/2003
8
Complementary DNA (cDNA)
IBA
07/2011 - 11/2002
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2013 - 03/2007
6
Transcription Factors (Transcription Factor)
IBA
05/2014 - 06/2003
6
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
09/2010 - 09/2006
6
tissue-factor-pathway inhibitor 2 (PP5)
IBA
06/2007 - 01/2002
5
Cysteine Proteases (Cysteine Protease)
IBA
09/2012 - 03/2004
5
Thromboplastin (Tissue Factor)
IBA
06/2007 - 01/2002
4
Double-Stranded RNA (RNA, Double Stranded)
IBA
11/2020 - 06/2004
4
Caspase 9
IBA
11/2012 - 03/2004
4
Cadherins (E-Cadherin)
IBA
11/2012 - 03/2011
4
Therapeutic Uses
IBA
06/2012 - 03/2004
4
Cytochromes c (Cytochrome c)
IBA
02/2012 - 01/2003
4
Caspase 8 (Caspase-8)
IBA
05/2011 - 10/2009
4
Caspases
IBA
10/2008 - 01/2003
3
Cysteine (L-Cysteine)
FDA Link
02/2013 - 12/2006
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2013 - 09/2010
3
Serine Proteases (Serine Protease)
IBA
09/2012 - 06/2006
3
Catenins
IBA
06/2012 - 10/2011
3
Metalloproteases (Metalloproteinases)
IBA
10/2011 - 06/2004
3
Endopeptidases
IBA
04/2011 - 08/2002
3
RNA (Ribonucleic Acid)
IBA
04/2011 - 05/2004
3
Phosphotransferases (Kinase)
IBA
03/2011 - 11/2007
3
Lipids
IBA
12/2010 - 09/2010
3
Caspase 3 (Caspase-3)
IBA
07/2010 - 05/2009
3
NF-kappa B (NF-kB)
IBA
06/2008 - 04/2007
3
Gelatin
IBA
03/2008 - 09/2005
3
Enzymes
IBA
07/2007 - 11/2002
3
Protease Inhibitors (Protease Inhibitor)
IBA
06/2007 - 12/2002
2
Calcineurin
IBA
04/2021 - 03/2012
2
Histone Deacetylases (Histone Deacetylase)
IBA
01/2020 - 12/2007
2
Collagen
IBA
10/2013 - 05/2009
2
Vitronectin
IBA
10/2013 - 07/2007
2
Gemcitabine
FDA Link
09/2013 - 02/2012
2
Angiogenesis Inhibitors
IBA
01/2013 - 10/2008
2
Temozolomide (Temodar)
FDA Link
Generic
11/2012 - 01/2008
2
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
11/2012 - 07/2012
2
Cyclin D1
IBA
07/2012 - 03/2011
2
Cytokines
IBA
06/2012 - 12/2010
2
Vimentin
IBA
12/2011 - 03/2011
2
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
10/2011 - 08/2011
2
angiogenin
IBA
08/2011 - 08/2010
2
Zinc
IBA
04/2011 - 03/2008
2
Focal Adhesion Protein-Tyrosine Kinases
IBA
02/2011 - 11/2010
2
ErbB Receptors (EGF Receptor)
IBA
12/2010 - 07/2007
2
Integrin alphaVbeta3
IBA
09/2010 - 03/2007
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
09/2010 - 01/2003
2
Histone Deacetylase Inhibitors
IBA
08/2010 - 12/2007
2
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2010 - 12/2009
2
Luciferases
IBA
05/2010 - 01/2002
2
Methyltransferases
IBA
01/2010 - 07/2003
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2009 - 11/2007
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2009 - 01/2008
2
Mitogen-Activated Protein Kinases
IBA
05/2007 - 04/2005
2
Decitabine
FDA Link
04/2005 - 07/2003
2
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
06/2003 - 01/2002
1
NG-Nitroarginine Methyl Ester (L-NAME)
IBA
12/2013
Therapy/Procedure
39
Therapeutics
02/2014 - 12/2002
14
Radiotherapy
02/2013 - 06/2008
6
Drug Therapy (Chemotherapy)
11/2012 - 06/2007
6
Injections
06/2006 - 11/2002
2
Aftercare (After-Treatment)
12/2013 - 11/2007
2
Intraperitoneal Injections
08/2010 - 07/2007